Literature DB >> 25207384

Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes.

Heike A Bischoff-Ferrari.   

Abstract

Recent evidence suggests that vitamin D deficiency has harmful effects on health and that recent vitamin D intake recommendations may be associated with better health outcomes. In this chapter, evidence is summarized from different studies that evaluate threshold levels for serum 25(OH)D levels in relation to bone mineral density (BMD), lower extremity function, dental health, risk of falls, fractures, cancer prevention, incident hypertension and mortality. For all endpoints, levels in the deficient range (< 50 nmol/l; < 20 ng/ml) are associated with no benefit or adverse effects, while the most advantageous serum levels for 25(OH)D appeared to be close to 75 nmol/l (30 ng/ml). An intake of 800 IU (20 microg) of vitamin D3 (cholecalciferol) per day for all adults may bring 97% of the population to level of at least 50 nmol/l and about 50% up to 75 nmol/l. Thus, higher doses of vitamin D than currently recommended are needed to bring most individuals to75 nmol/l. While estimates suggest that 1600 to 2000 IU vitamin D3 per day may successfully and safely achieve this goal, the implications of higher doses for the total adult population need to be addressed in future studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25207384     DOI: 10.1007/978-1-4939-0437-2_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  30 in total

1.  [Identification, diagnostics and guideline conform therapy of osteoporosis (DVO) in trauma patients : a treatment algorithm].

Authors:  C Neuerburg; R Schmidmaier; S Schilling; C Kammerlander; W Böcker; W Mutschler; U Stumpf
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

2.  Effects of 12 Weeks of Essential Amino Acids (EAA)-Based Multi-Ingredient Nutritional Supplementation on Muscle Mass, Muscle Strength, Muscle Power and Fatigue in Healthy Elderly Subjects: A Randomized Controlled Double-Blind Study.

Authors:  M Negro; S Perna; D Spadaccini; L Castelli; L Calanni; M Barbero; C Cescon; M Rondanelli; G D'Antona
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency.

Authors:  Tom D Thacher; Philip R Fischer; Ravinder J Singh; Jeffrey Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

4.  Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves' disease.

Authors:  X Li; G Wang; Z Lu; M Chen; J Tan; X Fang
Journal:  J Endocrinol Invest       Date:  2015-03-04       Impact factor: 4.256

5.  Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis.

Authors:  Yong Liao; Jian-Lin Huang; Ming-Xing Qiu; Zhi-Wei Ma
Journal:  Tumour Biol       Date:  2014-10-31

6.  Safety and Efficacy of High-dose Daily Vitamin D3 Supplementation in Children and Young Adults With Sickle Cell Disease.

Authors:  Kelly A Dougherty; Chiara Bertolaso; Joan I Schall; Kim Smith-Whitley; Virginia A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2015-07       Impact factor: 1.289

7.  Association of Maternal Vitamin D Deficiency with Early Childhood Caries.

Authors:  R Singleton; G Day; T Thomas; R Schroth; J Klejka; D Lenaker; J Berner
Journal:  J Dent Res       Date:  2019-03-14       Impact factor: 6.116

8.  Vitamin D and Age-Related Health Outcomes: Movement, Mood, and Memory.

Authors:  Denise K Houston
Journal:  Curr Nutr Rep       Date:  2015-05-08

9.  Influence of Vitamin D and Parathyroid Hormone on Bone and Metabolic Risk in Women with Previous Gestational Diabetes.

Authors:  M C Serra; A S Ryan
Journal:  Horm Metab Res       Date:  2016-02-16       Impact factor: 2.936

10.  A Guide to Improving the Care of Patients with Fragility Fractures, Edition 2.

Authors:  Simon C Mears; Stephen L Kates
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.